Substance / Medication

Tolmetin

Overview

Active Ingredient
tolmetin
RxNorm CUI
10636

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Species difference in the in vitro and in vivo metabolism of amtolmetin guacil.
Hotha Kishore Kumar, Dasari Vijaya Bharathi, Shaik Abdul Naveed et al. · Arzneimittelforschung · 2010
PMID: 21175039Observational
In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems. Comparison with non-selective and COX-2 selective NSAIDs.
Kirkova M, Alexandova A, Kesiova M et al. · Auton Autacoid Pharmacol · 2007
PMID: 17391279Observational
Impact on the bowel of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug.
Tubaro Ezio, Belogi Luisella, Mezzadri Carla Maria et al. · Eur J Pharmacol · 2003
PMID: 12706472Observational
Quantitation of tolmetin by high-performance liquid chromatography and method validation.
Chen Fu-An, Chen Chau-Yang, Chen Chih-Jui et al. · J Chromatogr Sci · 2003
PMID: 12908956Observational
Identification of coenzyme A-related tolmetin metabolites in rats: relationship with reactive drug metabolites.
Olsen J, Bjørnsdottir I, Honorè Hansen S · Xenobiotica · 2003
PMID: 12746110Observational
Potential-Modulated Surface-Enhanced Raman Spectroscopy of Tolmetin at Gold Nanoparticle Film Functionalized Polarizable Liquid-Liquid Interfaces.
Tarabet Madjid, Muñoz Nataly Rey, Scanlon Micheál D et al. · J Phys Chem C Nanomater Interfaces · 2024
PMID: 38774155OtherFull text (PMC)
Spectrofluorometric Turn-Off Sensing Probe for Tolmetin Determination Using Cerium and Nitrogen Codoped Carbon Dots.
Mabrouk Mokhtar M, Mansour Fotouh R, Hassan Hamsa B et al. · Luminescence · 2024
PMID: 39472300Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Tolmetin (substance)
SNOMED CT
372748008
UMLS CUI
C0040377
RxNorm CUI
10636

Clinical Data

This intervention maps to 9 entities in the Healos knowledge graph.

4
Conditions
2
Biomarkers
1
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.